PDF herunterladen
Thromb Haemost 2011; 106(05): 978-984
DOI: 10.1160/TH11-06-0371
New Technologies, Diagnostic Tools and Drugs
Schattauer GmbH

Cardiac troponin testing and the simplified Pulmonary Embolism Severity Index

The SWIss Venous ThromboEmbolism Registry (SWIVTER)
David Spirk
1   Medical Affairs, Sanofi-Aventis (Suisse) SA, Meyrin, Switzerland
,
Drahomir Aujesky
2   Division of General Internal Medicine, Bern University Hospital, Bern, Switzerland
,
Marc Husmann
3   Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland
,
Daniel Hayoz
4   Department of Internal Medicine, Cantonal Hospital Fribourg, Fribourg, Switzerland
,
Thomas Baldi
5   Department of Internal Medicine, University Hospital Basel, Basel, Switzerland
,
Beat Frauchiger
6   Department of Internal Medicine, Cantonal Hospital Frauenfeld, Frauenfeld, Switzerland
,
Martin Banyai
7   Department of Internal Medicine, Cantonal Hospital Lucerne, Lucerne, Switzerland
,
Iris Baumgartner
8   Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland
,
Nils Kucher
8   Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland
› Institutsangaben Financial support: This work was supported by Sanofi-Aventis (Suisse) SA, Meyrin, Switzerland. Data collection, data management, database entry, and data analysis were independent from the sponsor.
Weitere Informationen

Publikationsverlauf

Received: 01. Juni 2011

Accepted after major revision: 15. Juli 2011

Publikationsdatum:
23. November 2017 (online)

Auch verfügbar auf
  als PDF herunterladen  Lizenzen und Reprints

Summary

A low simplified Pulmonary Embolism Severity Index (sPESI), defined as age ≤80 years and absence of systemic hypotension, tachycardia, hypoxia, cancer, heart failure, and lung disease, identifies low-risk patients with acute pulmonary embolism (PE). It is unknown whether cardiac troponin testing improves the prediction of clinical outcomes if the sPESI is not low. In the prospective Swiss Venous Thromboembolism Registry, 369 patients with acute PE and a troponin test (conventional troponin T or I, highly sensitive troponin T) were enrolled from 18 hospitals. A positive test result was defined as a troponin level above the manufacturers assay threshold. Among the 106 (29%) patients with low sPESI, the rate of mortality or PE recurrence at 30 days was 1.0%. Among the 263 (71%) patients with high sPESI, 177 (67%) were troponin-negative and 86 (33%) troponin-positive; the rate of mortality or PE recurrence at 30 days was 4.6% vs. 12.8% (p=0.015), respectively. Overall, risk assessment with a troponin test (hazard ratio [HR] 3.39, 95% confidence interval [CI] 1.38–8.37; p=0.008) maintained its prognostic value for mortality or PE recurrence when adjusted for sPESI (HR 5.80, 95%CI 0.76–44.10; p=0.09). The combination of sPESI with a troponin test resulted in a greater area under the receiver-operating characteristic curve (HR 0.72, 95% CI 0.63–0.81) than sPESI alone (HR 0.63, 95% CI 0.57–0.68) (p=0.023). In conclusion, although cardiac troponin testing may not be required in patients with a low sPESI, it adds prognostic value for early death and recurrence for patients with a high sPESI.

Keywords

Pulmonary embolism - risk stratification - Pulmonary Embolism Severity Index - cardiac troponin
 

  • References

  • 1 Kasper W, Konstantinides S, Geibel A. et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997; 30: 1165-1171.
    CrossrefPubMedSuche in Google Scholar
  • 2 Kucher N, Rossi E, De Rosa M. et al. Massive pulmonary embolism. Circulation. 2006; 113: 577-582.
    CrossrefPubMedSuche in Google Scholar
  • 3 Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-1389.
    CrossrefPubMedSuche in Google Scholar
  • 4 Kucher N, Rossi E, De Rosa M. et al. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med 2005; 165: 1777-1781.
    CrossrefPubMedSuche in Google Scholar
  • 5 Ribeiro A, Lindmarker P, Juhlin-Dannfelt A. et al. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J 1997; 134: 479-487.
    CrossrefPubMedSuche in Google Scholar
  • 6 Stein PD, Matta F, Janjua M. et al. Outcome in stable patients with acute pulmonary embolism who had right ventricular enlargement and/or elevated levels of troponin I. Am J Cardiol 2010; 106: 558-563.
    CrossrefPubMedSuche in Google Scholar
  • 7 Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007; 116: 427-433.
    CrossrefPubMedSuche in Google Scholar
  • 8 Binder L, Pieske B, Olschewski M. et al. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 2005; 112: 1573-1579.
    CrossrefPubMedSuche in Google Scholar
  • 9 Konstantinides S, Geibel A, Olschewski M. et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002; 106: 1263-1268.
    CrossrefPubMedSuche in Google Scholar
  • 10 Kostrubiec M, Pruszczyk P, Bochowicz A. et al. Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J 2005; 26: 2166-2172.
    CrossrefPubMedSuche in Google Scholar
  • 11 Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 2003; 107: 2545-2547.
    CrossrefPubMedSuche in Google Scholar
  • 12 Lankeit M, Friesen D, Aschoff J. et al. Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism. Eur Heart J 2010; 31: 1836-1844.
    CrossrefPubMedSuche in Google Scholar
  • 13 Meyer T, Binder L, Hruska N. et al. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol 2000; 36: 1632-1636.
    CrossrefPubMedSuche in Google Scholar
  • 14 ten Wolde M, Tulevski II, Mulder JW. et al. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation 2003; 107: 2082-2084.
    CrossrefPubMedSuche in Google Scholar
  • 15 Torbicki A, Perrier A, Konstantinides S. et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29: 2276-2315.
    CrossrefPubMedSuche in Google Scholar
  • 16 Kearon C, Kahn SR, Agnelli G. et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (Suppl. 06) 454S-545S.
    CrossrefPubMedSuche in Google Scholar
  • 17 Aujesky D, Perrier A, Roy PM. et al. Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. J Intern Med 2007; 261: 597-604.
    CrossrefPubMedSuche in Google Scholar
  • 18 Chan CM, Woods C, Shorr AF. The validation and reproducibility of the pulmonary embolism severity index. J Thromb Haemost 2010; 8: 1509-1514.
    CrossrefPubMedSuche in Google Scholar
  • 19 Fraga M, Taffe P, Mean M. et al. The inter-rater reliability of the Pulmonary Embolism Severity Index. Thromb Haemost 2010; 104: 1258-1262.
    Thieme ConnectPubMedSuche in Google Scholar
  • 20 Jimenez D, Aujesky D, Moores L. et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010; 170: 1383-1389.
    CrossrefPubMedSuche in Google Scholar
  • 21 Moores L, Aujesky D, Jimenez D. et al. Pulmonary Embolism Severity Index and troponin testing for the selection of low-risk patients with acute symptomatic pulmonary embolism. J Thromb Haemost 2010; 8: 517-522.
    CrossrefPubMedSuche in Google Scholar
  • 22 Singanayagam A, Scally C, Al-Khairalla MZ. et al. Are biomarkers additive to pulmonary embolism severity index for severity assessment in normotensive patients with acute pulmonary embolism?. QJM 2011; 104: 125-131.
    CrossrefPubMedSuche in Google Scholar
  • 23 Stein PD, Fowler SE, Goodman LR. et al. Multidetector Computer Tomography for Acute Pulmonary Embolism. N Engl J Med 2006; 354: 2317-2327.
    CrossrefPubMedSuche in Google Scholar
  • 24 Palmieri V, Gallotta G, Rendina D. et al. Troponin I and right ventricle dysfunction for risk assessment in patients with nonmassive pulmonary embolism in the Emergency Department in combination with clinically based risk score. Intern Emerg Med 2008; 3: 131-138.
    CrossrefPubMedSuche in Google Scholar
  • 25 Jiménez D, Aujesky D, Moores L. et al. Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism. Thorax 2011; 66: 75-81.
    CrossrefPubMedSuche in Google Scholar